Menu Back toDIA Medical Affairs forum 2021 in Japan

DIA Medical Affairs forum 2021 in Japan

All prices are exclusive of 10% Japanese consumption tax

Overview

Click Here to View the Program in Japanese

The WEB registration has been closed. Please contact DIA Japan if you want to Join the Forum.

Program Committee

  • Shinichi  Nishiuma, MD
    Shinichi Nishiuma, MD Head of Oncology Medical Science, Japan medical
    BMS, Japan
  • Tadashi  Urashima, PhD
    Tadashi Urashima, PhD Performance and Digital Analytics Lead, Medical & Development Excellence Japan
    GlaxoSmithKline K.K., Japan
  • Takeshi  Ishido
    Takeshi Ishido Sr Manager, Medical Contetn, Medical Excellence
    Bristol-Myers Squibb.K.K. , Japan
  • Sonoko  Misawa, MD, PhD
    Sonoko Misawa, MD, PhD Associate Professor
    Chiba University, Japan
  • Hideki  Ninomiya, MD
    Hideki Ninomiya, MD CEO
    Datack Inc, Japan
  • Yoshiyuki  Sugimoto
    Yoshiyuki Sugimoto Medical Manager
    Sanofi K.K., Japan
  • Mitsutoshi  Toda, MBA
    Mitsutoshi Toda, MBA Group Manager, CRM Medical Franchise Dept. Japan Medical Division
    Novartis Pharma K.K., Japan
  • Shuji  Uno, PhD
    Shuji Uno, PhD Medical Lead, Hematology, Japan Medical
    Bristol-Myers Squibb K.K., Japan
  • Tetsuya  Watanabe, RPh
    Tetsuya Watanabe, RPh Senior Medical Director, Medical Affairs
    Astellas Pharma Inc., Japan
Load More